Heart failure in children: Etiology and treatment

Journal of Pediatrics

Volumn 165, Issue 2, 2014, Pages 228-233

  Rossano, Joseph W ^a   Shaddy, Robert E ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

ACE; Angiotensin converting enzyme; B type natriuretic peptide; BNP; ECMO; Extracorporeal membrane oxygenation; VAD; Ventricular assist device

Indexed keywords

ALDOSTERONE ANTAGONIST; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; TROPONIN;

ARTICLE; ASSISTED CIRCULATION; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CHILD; CHILD DEVELOPMENT; CHILD GROWTH; CHILD HOSPITALIZATION; CHILDHOOD DISEASE; CHILDHOOD MORTALITY; ECHOCARDIOGRAPHY; EVIDENCE BASED MEDICINE; EXERCISE; EXTRACORPOREAL OXYGENATION; FAMILY HISTORY; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MURMUR; HEART RIGHT VENTRICLE PRESSURE; HEART SOUND; HEART TRANSPLANTATION; HEPATOMEGALY; HUMAN; INCIDENCE; INFECTION; JUGULAR VEIN; MEDICAL HISTORY; PATHOPHYSIOLOGY; PERIPHERAL EDEMA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT EXAMINATION; RISK ASSESSMENT; UNITED STATES; VENTRICULAR ASSIST DEVICE; VITAL SIGN;

CHILD; HEART FAILURE; HUMANS; RISK FACTORS;

EID: 84904968728     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2014.04.055     Document Type: Article

References (57)

1. D.T. Hsu, and G.D. Pearson Heart failure in children: part I: history, etiology, and pathophysiology Circ Heart Fail 2 2009 63 70
2. C.W. Yancy, M. Jessup, B. Bozkurt, J. Butler, D.E. Casey Jr., and M.H. Drazner et al. 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation 128 2013 1810 1852
3. A.S. Go, D. Mozaffarian, V.L. Roger, E.J. Benjamin, J.D. Berry, and M.J. Blaha et al. Heart disease and stroke statistics-2014 update: a report from the American Heart Association Circulation 127 2013 e6 e245
4. J.W. Rossano, J.J. Kim, J.A. Decker, J.F. Price, F. Zafar, and D.E. Graves et al. Prevalence, morbidity, and mortality of heart failure-related hospitalizations in children in the United States: a population-based study J Card Fail 18 2012 459 470
5. C. Sommers, B.H. Nagel, U. Neudorf, and A.A. Schmaltz Congestive heart failure in childhood. An epidemiologic study Herz 30 2005 652 662
6. M.M. Massin, I. Astadicko, and H. Dessy Epidemiology of heart failure in a tertiary pediatric center Clin Cardiol 31 2008 388 391
7. P. Shamszad, M. Hall, J.W. Rossano, S.W. Denfield, J.D. Knudson, and D.J. Penny et al. Characteristics and outcomes of heart failure-related intensive care unit admissions in children with cardiomyopathy J Card Fail 19 2013 672 677
8. J.F. Price, A.R. Mott, H.A. Dickerson, J.L. Jefferies, D.P. Nelson, and A.C. Chang et al. Worsening renal function in children hospitalized with decompensated heart failure: evidence for a pediatric cardiorenal syndrome? Pediatr Crit Care Med 9 2008 279 284
9. S.E. Lipshultz, L.A. Sleeper, J.A. Towbin, A.M. Lowe, E.J. Orav, and G.F. Cox et al. The incidence of pediatric cardiomyopathy in two regions of the United States N Engl J Med 348 2003 1647 1655
10. A.W. Nugent, P.E. Daubeney, P. Chondros, J.B. Carlin, M. Cheung, and L.C. Wilkinson et al. The epidemiology of childhood cardiomyopathy in Australia N Engl J Med 348 2003 1639 1646
11. R.E. Andrews, M.J. Fenton, D.A. Ridout, M. Burch British Congenital Cardiac Association New-onset heart failure due to heart muscle disease in childhood: a prospective study in the United Kingdom and Ireland Circulation 117 2008 79 84
12. P.E. Daubeney, A.W. Nugent, P. Chondros, J.B. Carlin, S.D. Colan, and M. Cheung et al. Clinical features and outcomes of childhood dilated cardiomyopathy: results from a national population-based study Circulation 114 2006 2671 2678
13. J.A. Towbin, A.M. Lowe, S.D. Colan, L.A. Sleeper, E.J. Orav, and S. Clunie et al. Incidence, causes, and outcomes of dilated cardiomyopathy in children JAMA 296 2006 1867 1876
14. P.F. Kantor, J.R. Abraham, A.I. Dipchand, L.N. Benson, and A.N. Redington The impact of changing medical therapy on transplantation-free survival in pediatric dilated cardiomyopathy J Am Coll Cardiol 55 2010 1377 1384
15. J.J. O'Sullivan, S.L. Roche, D.S. Crossland, M.P. Chaudhari, R.C. Kirk, and H. Asif Recovery of heart function in children with acute severe heart failure Transplantation 85 2008 975 979
16. D.T. Hsu, S. Mital, C. Ravishankar, R. Margossian, J.S. Li, and L.A. Sleeper et al. Rationale and design of a trial of angiotensin-converting enzyme inhibition in infants with single ventricle Am Heart J 157 2009 37 45
17. E. Pahl, L.A. Sleeper, C.E. Canter, D.T. Hsu, M. Lu, and S.A. Webber et al. Incidence of and risk factors for sudden cardiac death in children with dilated cardiomyopathy: a report from the Pediatric Cardiomyopathy Registry J Am Coll Cardiol 59 2012 607 615
18. R.D. Ross The Ross classification for heart failure in children after 25 years: a review and an age-stratified revision Pediatr Cardiol 33 2012 1295 1300
19. A. Patange, R. Thomas, and R.D. Ross Severity of mitral regurgitation predicts risk of death or cardiac transplantation in children with idiopathic dilated cardiomyopathy Pediatr Cardiol 35 2014 232 238
20. M.C. Johns, and C. Stephenson Amino-terminal pro-B-type natriuretic peptide testing in neonatal and pediatric patients Am J Cardiol 101 2008 76 81
21. Y.M. Law, A.W. Hoyer, M.D. Reller, and M. Silberbach Accuracy of plasma B-type natriuretic peptide to diagnose significant cardiovascular disease in children: the Better Not Pout Children! Study J Am Coll Cardiol 54 2009 1467 1475
22. S.R. Auerbach, M.E. Richmond, J.M. Lamour, E.D. Blume, L.J. Addonizio, and R.E. Shaddy et al. BNP levels predict outcome in pediatric heart failure patients: post hoc analysis of the Pediatric Carvedilol Trial Circ Heart Fail 3 2010 606 611
23. B.B. Das Plasma B-type natriuretic peptides in children with cardiovascular diseases Pediatr Cardiol 31 2010 1135 1145
24. J.F. Price, A.K. Thomas, M. Grenier, B.W. Eidem, E. O'Brian Smith, and S.W. Denfield et al. B-type natriuretic peptide predicts adverse cardiovascular events in pediatric outpatients with chronic left ventricular systolic dysfunction Circulation 114 2006 1063 1069
25. D.T. Wong, K. George, J. Wilson, C. Manlhiot, B.W. McCrindle, and K. Adeli et al. Effectiveness of serial increases in amino-terminal pro-B-type natriuretic peptide levels to indicate the need for mechanical circulatory support in children with acute decompensated heart failure Am J Cardiol 107 2011 573 578
26. T. Ahmad, and C.M. O'Connor Therapeutic implications of biomarkers in chronic heart failure Clin Pharmacol Ther 94 2013 468 479
27. S.A. Hunt, W.T. Abraham, M.H. Chin, A.M. Feldman, G.S. Francis, and T.G. Ganiats et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult-summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) J Am Coll Cardiol 46 2005 1116 1143
28. D. Duboc, C. Meune, G. Lerebours, J.Y. Devaux, G. Vaksmann, and H.M. Becane Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy J Am Coll Cardiol 45 2005 855 857
29. D. Duboc, C. Meune, B. Pierre, K. Wahbi, B. Eymard, and A. Toutain et al. Perindopril preventive treatment on mortality in Duchenne muscular dystrophy: 10 years' follow-up Am Heart J 154 2007 596 602
30. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group N Engl J Med 316 1987 1429 1435
31. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators N Engl J Med 325 1991 293 302
32. M.R. Bristow, E.M. Gilbert, W.T. Abraham, K.F. Adams, M.B. Fowler, and R.E. Hershberger et al. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators Circulation 94 1996 2807 2816
33. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF) Lancet 353 1999 2001 2007
34. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial Lancet 353 1999 9 13
35. M. Packer, M.B. Fowler, E.B. Roecker, A.J. Coats, H.A. Katus, and H. Krum et al. Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study Circulation 106 2002 2194 2199
36. B. Pitt, F. Zannad, W.J. Remme, R. Cody, A. Castaigne, and A. Perez et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators N Engl J Med 341 1999 709 717
37. B. Pitt, W. Remme, F. Zannad, J. Neaton, F. Martinez, and B. Roniker et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction N Engl J Med 348 2003 1309 1321
38. D. Rosenthal, M.R. Chrisant, E. Edens, L. Mahony, C. Canter, and S. Colan et al. International Society for Heart and Lung Transplantation: Practice guidelines for management of heart failure in children J Heart Lung Transplant 23 2004 1313 1333
39. R.E. Shaddy, M.M. Boucek, D.T. Hsu, R.J. Boucek, C.E. Canter, and L. Mahony et al. Carvedilol for children and adolescents with heart failure: a randomized controlled trial JAMA 298 2007 1171 1179
40. P.F. Kantor, J. Lougheed, A. Dancea, M. McGillion, N. Barbosa, and C. Chan et al. Presentation, diagnosis, and medical management of heart failure in children: Canadian Cardiovascular Society guidelines Can J Cardiol 29 2013 1535 1552
41. J.L. Jefferies, B.W. Eidem, J.W. Belmont, W.J. Craigen, S.M. Ware, and S.D. Fernbach et al. Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy Circulation 112 2005 2799 2804
42. L. Viollet, P.T. Thrush, K.M. Flanigan, J.R. Mendell, and H.D. Allen Effects of angiotensin-converting enzyme inhibitors and/or beta blockers on the cardiomyopathy in Duchenne muscular dystrophy Am J Cardiol 110 2012 98 102
43. T. van der Bom, M.M. Winter, B.J. Bouma, M. Groenink, H.W. Vliegen, and P.G. Pieper et al. Effect of valsartan on systemic right ventricular function: a double-blind, randomized, placebo-controlled pilot trial Circulation 127 2013 322 330
44. M. Packer, J.R. Carver, R.J. Rodeheffer, R.J. Ivanhoe, R. DiBianco, S.M. Zeldis for The PROMISE Study Research Group Effect of oral milrinone on mortality in severe chronic heart failure N Engl J Med 325 1991 1468 1475
45. W.T. Abraham, K.F. Adams, G.C. Fonarow, M.R. Costanzo, R.L. Berkowitz, and T.H. LeJemtel et al. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE) J Am Coll Cardiol 46 2005 57 64
46. M.S. Cuffe, R.M. Califf, K.F. Adams Jr., R. Benza, R. Bourge, and W.S. Colucci et al. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial JAMA 287 2002 1541 1547
47. M.J. O'Connor, D.N. Rosenthal, and R.E. Shaddy Outpatient management of pediatric heart failure Heart Fail Clin 6 2010 515 529 ix
48. D. Mah, T.P. Singh, R.R. Thiagarajan, K. Gauvreau, G.E. Piercey, and E.D. Blume et al. Incidence and risk factors for mortality in infants awaiting heart transplantation in the USA J Heart Lung Transplant 28 2009 1292 1298
49. C.S. Almond, R.R. Thiagarajan, G.E. Piercey, K. Gauvreau, E.D. Blume, and H.J. Bastardi et al. Waiting list mortality among children listed for heart transplantation in the United States Circulation 119 2009 717 727
50. C.D. Fraser Jr., R.D. Jaquiss, D.N. Rosenthal, T. Humpl, C.E. Canter, and E.H. Blackstone et al. Prospective trial of a pediatric ventricular assist device N Engl J Med 367 2012 532 541
51. J.T. Baldwin, H.S. Borovetz, B.W. Duncan, M.J. Gartner, R.K. Jarvik, and W.J. Weiss The National Heart, Lung, and Blood Institute Pediatric Circulatory Support Program: a summary of the 5-year experience Circulation 123 2011 1233 1240
52. C.J. VanderPluym, I.M. Rebeyka, D.B. Ross, and H. Buchholz The use of ventricular assist devices in pediatric patients with univentricular hearts J Thorac Cardiovasc Surg 141 2011 588 590
53. S. Weinstein, R. Bello, C. Pizarro, F. Fynn-Thompson, J. Kirklin, and K. Guleserian et al. The use of the Berlin Heart EXCOR in patients with functional single ventricle J Thorac Cardiovasc Surg 147 2014 697 705
54. J.W. Rossano, D.J. Goldberg, S. Fuller, C. Ravishankar, L.M. Montenegro, and J.W. Gaynor Successful use of the total artificial heart in the failing Fontan circulation Ann Thorac Surg 97 2014 1438 1440
55. I. Wilmot, D.L. Morales, J.F. Price, J.W. Rossano, J.J. Kim, and J.A. Decker et al. Effectiveness of mechanical circulatory support in children with acute fulminant and persistent myocarditis J Card Fail 17 2011 487 494
56. J.K. Kirklin, D.C. Naftel, R.L. Kormos, L.W. Stevenson, F.D. Pagani, and M.A. Miller et al. Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients J Heart Lung Transplant 32 2013 141 156
57. A. Amodeo, and R. Adorisio Left ventricular assist device in Duchenne cardiomyopathy: can we change the natural history of cardiac disease? Int J Cardiol 161 2012 e43